Year: 2019

Rovio Entertainment Oyj                             PÖRSSITIEDOTE                  22.11.2019 klo 18.45Rovio Entertainment Oyj– Omien osakkeiden hankinta 22.11.2019Helsingin PörssiPäivämäärä                                                22.11.2019Pörssikauppa                                             OstoOsakelaji                                                    ROVIOOsakemäärä                                               41 067            osakettaKeskihinta/osake                                        4,124954         euroaKokonaiskustannus                                    169 399,48      euroaYhtiön hallussa on 22.11.2019 tehtyjen kauppojen jälkeen 802 771 osaketta.Rovio Entertainment Oyj:n puolestaOP Yrityspankki OyjMarko Niemi                                Igor KilpeläinenLisätietoja:Rene Lindell, talousjohtaja+358 207 888 300...

TORONTO, Nov. 22, 2019 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (the “Company”) (CSE:IDK), a Canadian-based venture capital firm focused on investments in promising, early stage companies and ICOs with disruptive capabilities, is pleased to announce that it has completed a non-brokered private placement (the “Offering”), pursuant to which it has issued 5,000,000 units (“Units”) at a price of $0.033 per Unit, to raise aggregate gross proceeds of $165,000. Each Unit consists of one common share of the Company and one common share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to acquire one additional common share of the Company at an exercise price of $0.05 until November 22, 2022. All securities issued and issuable in connection with the Offering are subject to a statutory hold period expiring on March 23,...

Dear Madam, Sir,Please find hereafter our press release regarding the consolidated results for financial year 2018-2019.We remain at your entire disposal for any further information.Yours sincerely,AttachmentAnnual press release – 30.09.2019

Chère Madame, Cher Monsieur,Veuillez trouver ci-après notre communiqué de presse concernant les résultats annuels consolidés de l’exercice 2018-2019.Nous restons à votre entière disposition pour toute information complémentaire.Salutations respectueuses.Pièce jointeCommuniqué de presse annuel – 30.09.2019

Geachte Mevrouw, Mijnheer,Gelieve hierna ons persbericht te vinden met betrekking tot de geconsolideerde resultaten van het boekjaar 2018-2019.Hoogachtend,BijlageJaarlijks persbericht – 30.09.2019

VALCOURT, Quebec, Nov. 22, 2019 (GLOBE NEWSWIRE) — BRP Inc. (TSX:DOO; NASDAQ:DOOO) will hold its third quarter FY2020 financial results conference call on Wednesday, November 27, 2019.José Boisjoli, President and Chief Executive Officer, and Sébastien Martel, Chief Financial Officer, will present the results of the third quarter of FY2020 and address questions from analysts on a conference call at 9 a.m. (EST).The press release will be distributed on Canadian and American newswires on Wednesday, November 27 at approximately 6 a.m. (EST).For investors and analysts:Business media are allowed to join the call but will not be permitted to ask questions. This webcast will also be live on the Internet here and accessible to media and interested participants. An archived recording will be available here two hours after the event for 30...

VALCOURT, Québec, 22 nov. 2019 (GLOBE NEWSWIRE) — BRP Inc. (TSX: DOO; NASDAQ: DOOO) tiendra un appel conférence sur les résultats financiers de son troisième trimestre de l’année financière 2020 le mercredi 27 novembre 2019.José Boisjoli, président et chef de la direction, et Sébastien Martel, chef de la direction financière, présenteront les résultats du troisième trimestre de l’AF2020 et répondront aux questions des analystes à 9 h (HNE).Le communiqué de presse sera diffusé sur les fils de presse canadien et américain le mercredi 27 novembre, vers 6 h (HNE).Pour les investisseurs et les analystes :Les médias sont autorisés à participer à l’appel, mais ne pourront poser de questions. Cette webdiffusion sera également retransmise en direct sur Internet ici et accessible aux médias et aux participants intéressés. Un enregistrement...

Leverkusen, Germany, Nov. 22, 2019 (GLOBE NEWSWIRE) — Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its participation at the following events:Event: Deutsches Eigenkapitalforum / Analyst conferenceFormat: Presentation & 1×1 MeetingsDate: Monday, November 25, 2019Time: 5:00pm CETLocation: Sheraton Frankfurt Airport Hotel & Conference Center, Frankfurt/Main, GermanyEvent: Benchmark Discovery 1×1 ConferenceFormat: 1×1 MeetingsDate: Wednesday, December 4, 2019Location: The New York Athletic Club, New York, NYEvent: 12th Annual LD Micro Main EventFormat: Presentation & 1×1 MeetingsDate: Wednesday, December 11, 2019Time: 10:00am PTLocation: Luxe Sunset Boulevard Hotel, Los Angeles, CA: Track 2-End-About...

First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival in people with unresectable hepatocellular carcinoma compared with sorafenibResults will be presented in the Presidential session at the European Society for Medical Oncology (ESMO) Asia Congress 2019Basel, 22 November 2019 – Roche (SIX: RO, ROG; OTCQX: RHHBY) will today present positive results from the Phase III IMbrave150 study evaluating Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab). The data show statistically significant and clinically meaningful improvements in overall survival (OS) and progression-free survival (PFS), compared with sorafenib, in people with unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy.NE, not estimable (Median OS for Tecentriq...

                                                                                                                        Ress Life Investments                                                                                                                        Holbergsgade 14, 2 tv                                                                                                                        DK-1057 Copenhagen K                                                                                                                        Denmark                                                                                                                        CVR nr. 33593163                                                                                                                     www.resslifeinvestments.comTo: Nasdaq CopenhagenDate:...